Dr. Yassini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
131 Orange Ave
# 100
Coronado, CA 92118Phone+1 619-522-4005Fax+1 619-522-4014
Education & Training
University of California (San Diego) Medical CenterResidency, Family Medicine, 1997 - 2000
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Surgery, 1995 - 1997
West Virginia University School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 1997 - 2026- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
Clinical Trials
- Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59 Start of enrollment: 2018 Mar 15
Publications & Presentations
PubMed
- 17 citationsLocalized hypertrophic mononeuropathy involving spinal roots and associated with sacral meningocele Case reportPatrick R. Yassini, Kent Sauter, Sydney S. Schochet, Howard H. Kaufman, Stephen M. Bloomfield
Journal of Neurosurgery. 1993-11-01 - 4 citationsGlioma-stimulated chemoattraction of endothelial cells and fibroblastsin vitro: a model for the study of glioma-induced angiogenesisPatrick R. Yassini, D. L. Stickler, S. M. Bloomfield, Richard C. Wiggins, Gregory W. Konat
Metabolic Brain Disease. 1994-12-01 - Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults.Patrick Yassini, Mark Hutchens, Yamuna D Paila, Lorraine Schoch, Anne Aunins
Human Vaccines & Immunotherapeutics. 2023-12-31
Press Mentions
Inovio’s Recent Data Fails to Impress Some Analysts but Overall Data Looks Promising & Study Backed by Department of DefenseDecember 29th, 2020- You Are NOT Your Diagnosis, Says a Doctor with over 25 Years ExperienceJuly 4th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
